IRAK1BP1 inhibits inflammation by promoting nuclear translocation of NF-κB p50
- 7 June 2010
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (25) , 11477-11482
Abstract
An orchestrated balance of pro- and antiinflammatory cytokine release is critical for an innate immune response sufficient for pathogen defense without excessive detriment to host tissues. By using an unbiased forward genetic approach, we previously reported that IL-1R–associated kinase 1 binding protein 1 (IRAK1BP1) down-modulates Toll-like receptor-mediated transcription of several proinflammatory cytokines. To gain insights into the physiological relevance of the inhibitory role of IRAK1BP1 in inflammation, we generated mutant mice lacking IRAK1BP1. Here we report that IRAK1BP1 does not inhibit signaling pathways generally but rather changes the transcriptional profile of activated cells, leading to an increase in IL-10 production and promoting LPS tolerance. This shift in cytokine transcription correlates with an increased ratio of functional NF-κB subunit dimers comprised of p50/p50 homodimers relative to p50/p65 heterodimers. The increase in nuclear p50/p50 was consistent with the ability of IRAK1BP1 to bind to the p50 precursor molecule and IκB family member p105. We conclude that IRAK1BP1 functions through its effects on NF-κB as a molecular switch to bias innate immune pathways toward the resolution of inflammation.Keywords
This publication has 29 references indexed in Scilit:
- New regulators of NF-κB in inflammationNature Reviews Immunology, 2008
- Forward genetic analysis of Toll-like receptor responses in wild-derived mice reveals a novel antiinflammatory role for IRAK1BP1Journal of Experimental Medicine, 2008
- Gene-specific control of inflammation by TLR-induced chromatin modificationsNature, 2007
- NF-κB1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in MacrophagesJournal of Biological Chemistry, 2006
- The 20S proteasome processes NF‐κB1 p105 into p50 in a translation‐independent mannerThe EMBO Journal, 2006
- Negative regulation of Toll-like receptor-mediated immune responsesNature Reviews Immunology, 2005
- Pyogenic Bacterial Infections in Humans with IRAK-4 DeficiencyScience, 2003
- Points of control in inflammationNature, 2002
- The p50-homodimer mechanism in tolerance to LPSInnate Immunity, 2001
- SIMPL Is a Tumor Necrosis Factor-specific Regulator of Nuclear Factor-κB ActivityJournal of Biological Chemistry, 2001